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Decreased Cancer Consultations in
the COVID-19 Era: A Concern for Delay
in Early Cancer Diagnosis in India
The COVID-19 pandemic has caused unprecedented
impact across the globe, severely affecting the national
health systems, as well as mobility and commuting.
Several key health issues are inadvertently being
overlooked, bearing impact on mortality and other
outcomes, particularly for patients with cancer.
The recent global collaborative study that addressed
the impact of the SARS-Cov-2 surge on cancer care
not only reported on its varying magnitude among
centers worldwide but also further called for additional
research to assess this impact at the patient level.1
We too find this to be a major problem, as modeling
studies herald a general concern over COVID-
19–related delays in peri-management of oncological
patients, leading to an increased loss of life and life-
years linked to patient age and tumor type2-5 with
reports of an overall 55% decrease in referrals,
whereas the diagnostic yield increased from 2.9% in
January to 8.06% in April.2
Moreover, the pandemic appears to strengthen the
impact of pre-existing social disparities, making it
central that we address the social determinants of
health to provide equitable, high-quality care for pa-
tients with head and neck cancer,6 therefore over-
coming the reported impact of COVID-19 on
healthcare and socioeconomic systems in Asia
Pacific.7
As algorithms have been suggested to stratify patients
requiring head and neck cancer surgery in the COVID-
19 era,8 it is paramount that we do not lose sight of the
severe upstream impact leading to delayed diagnosis
or follow-up of survivors. In fact, this inordinate delay in
the examination and diagnosis of this ailment has
severely affected mortality and other outcomes, par-
ticularly for patients with cancer.3,9
Still, early diagnosis of cancer, although critical in
every respect, is mostly dependent on the patient’s
willingness to consult physicians and attend routine
examinations.9
Overall, the pandemic has forced a majority of patients
to approach healthcare centers only for emergency
treatments, thereby reducing the frequency of early
clinical examinations and hence detection of cancer.
After imposing a nationwide lockdown for two months,
India underwent three phases of unlocks: unlock 1
from June 1 to June 30, 2020; unlock 2 from July 1 to
July 31, 2020; and unlock 3 August 1 to August 31,
2020.10
The lockdown or unlock stipulations have significantly
affected the Indian cancer care system. As an ex-
ample, several of our 24 oncology centers across India
(HCG Cancer Hospitals) witnessed a cumulative drop
of new consultations (49.1%) immediately after the
lockdowns were imposed (Fig 1). Interestingly, we
noticed a gradual rise (9.9%) in new consultations
once the extension of lockdown was announced.
However, once the unlock was enforced, there was a
progressive decline in new consultations (12.1%).
In hindsight, the reasons for this pattern can be
gathered with reasonable accuracy. Initially, in the
early phase of the pandemic, the fear and panic linked
with announcement of lockdown and virus spread
might have forced patient to postpone their heath
checkups. With continuous imposition of restrictions
and prevailing uncertainties, the patients summoned
the courage to visit the hospitals and to get examined.
A matter of grave concern, however, is the progressive
gradual drop of new consultations (12.1%) even after
the announcement of the unlock.
Several factors could possibly explain the drop in new
consultations after the lockdown: (1) individuals with
nonspecific symptoms of cancer might have had some
anxiety about contracting COVID-19 during commut-
ing, as also within a healthcare setting; (2) many
patients may be unsure about the adequacy and
capacity of essential non-COVID-19–related health-
care services; (3) the misconception that COVID-19
testing is mandatory for undertaking any treatment at
hospital might have dissuaded patients from visiting
the health setting; (4) many government and private
cancer screening programs have been temporarily
halted or working at very slow pace even after the
unlock; and (5) the prevailing stay-at-home orders in
densely populated areas affect segments of the pop-
ulation known to share both an increased risk for
COVID-19 and for head and neck cancer.
The disturbing findings of fewer consultations even
after the announcement of unlock warrant immediate
attention. If the delay in early consultations continues
unabated, it may negatively influence early cancer
detection, resulting in increasing tumor burden and a
likely upstaging of TNM classification, negatively af-
fecting outcomes and overall quality of life of patients
with head and neck cancer.
As the COVID-19 pandemic appears still far from
declining, the healthcare system demands immediate
attention to quickly help restore it to normalcy. As
suggested by Dinmohamed et al,9 a couple of key
measures are the need of the hour: (1) individuals with
suspicious symptoms need to be proactively encour-
aged to consult their general practitioners and (2) the






guidance to policymakers for designing and delivering
public awareness programs.
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FIG 1. Number of cancer consultations by
month in India (data from 24 branches of
HCG cancer center) in the period between
January 1, 2020, and August 30, 2020.
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